check_circleStudy Completed

Vaginal yeast infection

Activity and tolerability of BAY b 5097 10% vaginal cream in subjects with vaginal Candida infections

Trial purpose

Please see attached Study Results Summary below

Key Participants Requirements

Sex

N/A

Age

16 - 41 Years
  • -

  • -

Trial summary

Enrollment Goal
34
Trial Dates
January 1982 - May 1982
Phase
N/A
Could I Receive a placebo
N/A
Products
Mycelex (Clotrimazole, BAYB5097)
Accepts Healthy Volunteer
N/A

Trial design

Open, mycologically controlled study to assess the activity and tolerability of BAY b 5097 10% vaginal cream in subjects with vaginal Candida infections
Trial Type
Interventional
Intervention Type
N/A
Trial Purpose
N/A
Allocation
N/A
Blinding
N/A
Assignment
N/A
Trial Arms
N/A